Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from...

Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies...

staphylococcus infections. In 2015, the company announced it would acquire Astellas Pharmas dermatology business for $725 million. In 2018, the company acquired...

this source, which is in the public domain. "Astellas to Acquire Ogeda SA" (Press release). Astellas Pharma. Archived from the original on 5 November 2021...

Year Ended March 31, 2021 Annual Report 2021 (PDF) (Report). Astellas. 31 March 2020. "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com....

(PDF). Astellas Pharma Inc. 31 March 2014. Archived from the original (PDF) on 4 September 2019. Retrieved 12 November 2016. "About Astellas". Astellas Pharma...

017. PMID 15261132. "CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM)" (PDF). Astellas Pharma US, Inc. "Rapiscan EPAR". European Medicines...

Russia and Iceland, it is marketed under the trade name Omnic by Astellas Pharma Europe. The largest manufacturer of tamsulosin is Synthon BV (the Netherlands)...

product pipeline includes enfortumab vedotin, being co-developed with Astellas Pharma, tisotumab vedotin, being co-developed with Genmab, SGN-LIV1A, an ADC...

in adults and children. A branded version of the drug is owned by Astellas Pharma, and is sold under the brand name Prograf, given twice daily. A number...